Rating: Cautiously Bullish | Target Price: RMB 7.8–8.3 (fair value range under the base scenario, midpoint RMB 8.0) | Current price: RMB 6.99 (close on 2026-10-08) | Margin of safety: +12% (vs. base fair value floor of RMB 7.8) | Time horizon: 12 months
Industry: Coal Mining (Jincheng Anthracite) + Coal Chemicals | Total shares outstanding: 1.473 billion | Total market cap: RMB 10.298 billion | PB 0.67 (2026H1 book value per share: RMB 10.36)
| Item | Last time (2026-07-03, price RMB 5.58) | This time (2026-10-08, price RMB 6.99) | Drivers of change |
|---|---|---|---|
| Rating | Cautiously bullish | Cautiously bullish (maintained) | Earnings inflection realized as expected, but the stock has risen 25% and the midpoint of the old target range has been reached; remaining odds have converged |
| Confidence | 0.50 | 0.55 | H1 recurring loss-to-profit turnaround and Q3 spot coal price surge validate the recovery direction; full shutdown of the chemical segment and the pending arbitration cap further upgrades |
| Target price range | RMB 6.5–7.5 | RMB 7.8–8.3 | Mid-cycle normalized earnings framework established: normalized net profit attributable to parent of ~RMB 900 million, exit PB of 0.75× 2027E book value per share, anchored independently of the current price |
| Valuation judgment | Undervalued | Modestly cheap | PB recovered from 0.54 to 0.67 (26th percentile over the past 5 years); the market has already priced in roughly 5× the annualized H1 earnings recovery; the discount has narrowed to the lower bound of the mid-cycle midpoint |
| Key new facts | — | ① H1 recurring net profit +RMB 95 million, turning profitable; ② mid-August full shutdown of three chemical subsidiaries, RMB 3.962 billion of technical upgrade commitments with trial production by 12-31; ③ Asia-Daning arbitration hearings held, unresolved for over 6 months; ④ short-term borrowings +85% in six months to RMB 4.35 billion | See details below |
Lanhua Sci-Tech's earnings inflection point has shifted from "expectation" to "reported fact": 2026H1 recurring net profit attributable to parent of +RMB 95 million (turnaround), realized coal selling price of RMB 565.07/ton (+16.3%), and another sharp jump in Q3 anthracite lump coal prices at production sites (Statistics Bureau ten-day report: +RMB 141 in a single ten-day period). However, after a 25% share price gain over three months, the implied expectations at the current price of RMB 6.99 have recovered to the lower bound of the mid-cycle midpoint — the coal price the market believes in (~RMB 567/ton) is almost identical to the actual H1 selling price, and further narrowing of the valuation discount must come mainly from earnings delivery rather than multiple expansion. We maintain our cautiously bullish rating: base case fair value RMB 7.8–8.3 (+11.6% to +18.7%), bear case RMB 4.8–5.5 (-21% to -31%), expected return +15.7% — a "verification-driven opportunity" rather than deep undervaluation. Three core constraints: first, the full shutdown of the chemical segment since mid-August means H2 fertilizer and chemical revenue will be essentially zero; second, the Asia-Daning arbitration (the Hong Kong party is the claimant, the company is the first respondent — branch mapping runs counter to intuition) is the single largest source of variance; third, net interest-bearing debt of RMB 11.37 billion (roughly 4.4× mid-cycle EBITDA) combined with zero dividends since 2025 caps the valuation ceiling.
Key drivers over the next 12 months: ① Coal price midpoint (every RMB 10/ton change in own-produced coal price → net profit attributable to parent ~±RMB 92 million; ±10% coal price → ±61% net profit — the primary driver); ② First-stage ruling in the Asia-Daning SIAC arbitration (extension approved = restart expectations + stopping the bleeding from an equity-method drag of ~RMB 190 million annualized in H1; extension rejected = ~RMB 340 million impairment + permanent loss of ~RMB 200 million/year in equity income — the largest swing factor between bull and bear distributions); ③ Coal chemical technical upgrade: mechanical completion handover by 10-31 and trial production by 12-31 (determines whether the chemical segment flips from drag to contributor in 2027).
Primary stock price driver: Anthracite pit-mouth coal prices. Leading indicators: the weekly Jincheng anthracite medium lump pit-mouth price index, Qinhuangdao Q5500 FOB price (10-08 spot basis: RMB 983–995/ton; note that the CCTD composite transaction price basis stood at RMB 754/ton in mid-September — the two bases differ by ~30%, so any threshold judgment must first specify the basis), Bohai Rim port inventories (support below 24 million tons), and the actual delivery of Shanxi's supply-guarantee restart (market estimates ~31 million tons of incremental supply).
Verifiable expectation gap: The sell-side consensus for FY2026 net profit attributable to parent is ~RMB 309 million (median of 9 estimates, netly revised down 32.3% over the past 90 days) — almost exactly equal to Q2's annualized run-rate, i.e., the market is pricing in "essentially no Q3 coal price gains flowing through." We forecast RMB 300–450 million (midpoint RMB 375 million), above consensus but already deducting three drags: urea margin going to zero, continued Asia-Daning losses, and the year-end impairment habit. The expectation gap lies in the transmission verification via the Q3 report and annual report, not in infinite extrapolation.
Validation and falsification: Q3 report (expected late October) — a quarter-on-quarter realized coal price increase of ≥+5% would validate transmission; falsification triggers: Qinhuangdao Q5500 (spot basis) falling below RMB 800/ton, comprehensive realized coal price falling below RMB 500/ton, rejection of the arbitration extension, or technical upgrade delay past March 2027 — any one triggers a downward re-rating. Opportunity structure: base-case upside +12% to +19%, bear-case downside -21% to -31%, probability-weighted +15.7% — suited to staged participation at catalyst points rather than a single large position.
Key evidence:
H1 revenue was RMB 4.792 billion (+18.3%), net profit attributable to parent RMB 83 million (+44.6%); Q2 alone delivered revenue of RMB 2.382 billion and net profit attributable to parent of ~RMB 110 million (H1 minus Q1), a marked sequential improvement. Management attributed revenue growth "mainly to higher selling prices for our main products, coal and urea, and increased coal sales volume." It must be emphasized that the full-year forecast of RMB 300–450 million already nets off three H2 drags: urea segment gross margin going to zero in Q4 (H1 gross margin for this item: RMB 113 million), continued Asia-Daning shutdown (H1 equity-method loss of -RMB 94 million), and the year-end impairment habit suggested by the concentrated impairments in Q4 2025 (single-quarter net profit attributable to parent of ~-RMB 550 million). If there are no unusual Q4 impairments and coal prices stay strong, results land at the upper end; if concentrated impairments recur, results trend toward the lower end or even management's target. The bearish counterargument holds that consensus (≈ Q2 annualized) is the rational anchor and Q3 gains may not materialize — we partially agree, hence the thesis confidence of 0.55 rather than higher.
Key evidence:
Reverse valuation shows that at RMB 6.99 the market believes in a coal price (~RMB 567/ton) almost identical to the realized H1 price of RMB 565 — this can be read two ways: optimists say "the market capitalizes only the current selling price in perpetuity, paying nothing for a cyclical recovery"; cautious observers say "the market has already annualized and amplified H1 earnings by ~5× (RMB 980 million vs. RMB 190 million)." We take a middle position: the pricing is modestly cheap, with the recovery space coming from convergence toward mid-cycle earnings of RMB 700–1,100 million in 2027, not from further multiple expansion. A peer PB×ROE unit comparison (Lanhua 0.67/6.1%≈0.110 vs. Lu'an 0.98/7.7%≈0.127, Huayang 1.19/7.6%≈0.157) supports the "discount is deep" judgment, but high leverage, zero dividends, and the twin overhangs of chemicals and arbitration constitute real reasons for the discount. Asset quality must be flagged: of the RMB 15.26 billion in net assets attributable to parent, RMB 7.31 billion is exploration rights plus construction in progress (RMB 1.996 billion cumulatively invested in the technical upgrade); an impairment test on the exploration rights would shrink the PB denominator. Also, the conclusion is sensitive to the cost of equity — at a COE of 10%, fair value is ~RMB 6.65, below the current price, so the margin of safety effectively depends on coal price strength persisting.
Key evidence:
Phasing out fixed-bed gasification is policy-mandated; the shutdown is essentially "out with the old, in with the new": the new units create capacity of 490,000 tons of synthetic ammonia / 560,000 tons of urea / 94,400 tons of LNG, replacing the 560,000 tons of old urea capacity being shut down. There are three layers of risk. First, as of 10-08 no handover progress announcement has been made; the 10-31 handover is an earlier validation point than 12-31. Second, the study's RMB 2,200/ton urea assumption is 26% above the H1 realized price of RMB 1,744, so early returns will likely fall short (every RMB 100/ton price gap × 1.2 million tons × 75% after tax ≈ -RMB 90 million attributable to parent). Third, H2 still requires ~RMB 2 billion in project final payments, creating a cash flow offset against profit recovery — the segment has lost money year after year (2025 aggregated total profit by subsidiary: -RMB 338 million), and construction in progress faces impairment-test pressure.
Key evidence:
The structure of the arbitration claim determines the branches: ① Ruling confirming extension to 2030-05-12 (company loses legally, wins commercially) → Daning restarts, restoring ~RMB 200 million/year in equity income for a limited term (~4.5 years) and stopping the current bleed of -RMB 94 million/half-year; however, it will likely proceed to a fifth-stage damages phase — with the Hong Kong party's 2024 net profit at RMB 510 million/year, a five-year-loss claim implies a theoretical damages ceiling of ~RMB 1.05 billion for the company's 41% share (the company's announcement says "to be assessed"; this ceiling is our own estimate); ② Extension rejected → the 4-million-ton associate mine's shutdown is locked in; 41% × net assets of RMB 2.370 billion = RMB 972 million, vs. a carrying value of RMB 1.315 billion, requiring an impairment of ~RMB 340 million, with the profit stream permanently extinguished. The ruling is already 6 months overdue, slower than the normal SIAC pace; the window for a decision is Q4-2027 Q1. The two branches swing EPS by a combined ~±RMB 0.14–0.20/year — the single largest variable in the bull/bear scenario distribution.
Key evidence:
The use of leverage is clear: in 2025 the Sitou exploration rights cost RMB 6.949 billion, plus the technical upgrade and Luhe construction — interest-bearing debt rose ~RMB 8.1 billion over two years. This is counter-cyclical resource buying plus expansionary capital allocation, at the cost of current interest expense (annualized H1 finance costs of ~RMB 450–500 million) devouring profits and dividend capacity. On the current basis, H1 operating cash flow of RMB 281 million cannot yet cover annualized interest; the substance of the "tight balance" is buying time with short-debt rollovers and credit headroom. Whether the RMB 3 billion corporate bond (approval valid for 24 months; not yet issued as of 10-08) is priced and at what coupon is a real-time thermometer for the credit channel. The 2024 payout ratio of 30.8% was still above the charter commitment; from 2025 onward there is zero dividend — shareholder returns yield to capital expenditure.
Key evidence:
Both readings must be laid side by side: Sitou's transaction price of RMB 34.7/ton of resources is at once a genuine market-based confirmation of Jincheng anthracite's scarcity (supporting resource revaluation) and a ~2.8× premium on a converted basis vs. coking coal comparables (supporting the "overpaid" critique). Moreover, the company's own Jiazhai exploration rights being listed for proposed revocation shows the "exploration rights → mining rights" administrative chain carries genuine revocation risk; Sitou is currently only in the exploration-to-mining verification and reserve filing stage, with no cash flow within 18 months. After deducting the zero-growth EPV of RMB 5.12/share from the current price, the remainder is ~RMB 1.87/share (~27%) — far below the cash cost of RMB 4.72/share the company paid for Sitou alone. The market's pricing of this resource option is extremely conservative; this may be a discount opportunity, or it may be rational pricing of execution risk and overpayment risk. Luhe's 900,000-ton capacity is slated for combined trial operation in March 2027 per the 2025 annual report (though the company also stated via e-interaction that "there are no near-term new capacity plans" — the discrepancy needs tracking); together with Yongsheng's lower-seam deepening already approved for trial operation, this constitutes a modest succession of own-produced output for 2027–2028.
| Metric | 2023FY | 2024FY | 2025FY | 2026H1 (latest period) |
|---|---|---|---|---|
| Operating revenue (RMB bn) | 13.284 | 11.697 | 8.142 | 4.792 (+18.3%) |
| Net profit attributable to parent (RMB bn) | 2.098 | 0.718 | -0.540 | 0.083 (+44.6%) |
| Recurring net profit attributable to parent (RMB bn) | 2.123 | — (not extracted) | -0.852 | 0.095 (turned profitable, +155.5%) |
| Gross margin | — (not extracted) | 26.1% | 18.9% | 28.0% |
| Net margin attributable to parent | 15.8% | 6.1% | -6.6% | 1.7% |
| Operating cash flow (RMB bn) | 2.673 | 1.903 | -0.342 | 0.281 (-0.460 in prior-year period) |
| Free cash flow (RMB bn) | — (not extracted) | 1.419 | -1.561 (standard basis; -8.511 including exploration right purchase) | -0.333 |
| Cash and cash equivalents (RMB bn, incl. restricted) | — | — | 4.304 (period-end) | 4.586 (as of 2026-06-30, incl. 0.654 restricted) |
| Interest-bearing debt (RMB bn) | — | 7.885 (period-end) | 14.689 (period-end) | 15.957 (as of 2026-06-30, 5.460 due within 1 year) |
| Debt-to-asset ratio | — | 47.54% | 59.40% | 60.37% |
| Net interest-bearing debt/EBITDA | — | — | — | approx. 4.4× (on mid-cycle normalized EBITDA of approx. RMB 2.6 bn; higher on current-period basis) |
Reasons for metric changes (YoY ≥ ±20% excerpts, all accompanied by company explanations): H1 revenue +18.3% — company explanation: "mainly due to higher selling prices of our main products, coal and urea, and increased coal sales volume"; short-term borrowings +85.02% — "mainly due to increased daily working-capital borrowings"; construction in progress +31.4% — "mainly due to increased investment in the coal chemical energy-saving and environmental upgrade project"; investment income -RMB 89 mn (prior-year period: -RMB 4 mn) — equity-method recognition of -RMB 94.20 mn from Yamei Daning's production halt; non-operating income -99.3% — prior-year period included a one-time gain of RMB 213 mn from the refund of investment in an acquired subsidiary. 2025FY: revenue -30.4% — "falling and volatile prices of major products such as coal, urea, and caprolactam, compounded by lower sales volume"; net profit attributable to parent -175% — including the offset of Q4 concentrated asset impairments of RMB 244 mn and one-time non-operating gains of RMB 403 mn; operating cash flow turned negative — price declines and shrinking sales volume.
2026H1 quick review: H1 represents a combination of "recovering coal prices + production contraction + eve of chemical-segment stop-loss" — coal sales of 6.7218 mn tonnes (+11.2%, incl. inventory drawdown) offset production of 6.9271 mn tonnes (-8.6%, tighter safety supervision); per-tonne coal price of RMB 565.07 (+16.3%) and cost of RMB 282.81 (+2.0%) improved in both directions, yielding per-tonne coal gross profit of approx. RMB 282; urea saw volume down, price up (production -3.9%, price +9.7%, unit cost -4.3%), with gross profit of RMB 113 mn (+210.9%). On profit structure, consolidated net profit was only RMB 2 mn, while the RMB 83 mn attributable to parent relied on minority shareholders absorbing -RMB 81 mn of losses (see the section "Financial Engineering and Cross-Period Consistency"); income tax of RMB 109 mn represented 98% of pre-tax profit, reflecting the structural mismatch of "profitable subsidiaries paying taxes while losses of loss-making subsidiaries are borne by minority shareholders." Against management's full-year targets (revenue RMB 9.2 bn, profit RMB 200 mn), H1 revenue reached 52% of schedule and pre-tax profit of RMB 111 mn already exceeded half — but with the full chemical shutdown in mid-August, fertilizer and chemical revenue in H2 will be essentially zero, so the revenue target will likely be just met or slightly missed, while the profit side may exceed the target thanks to coal prices. In terms of market expectations (sell-side consensus FY2026 net profit attributable to parent approx. RMB 309 mn, net downward revision of 32.3% over the past 90 days), the H1 absolute figure still lags the linear schedule — whether it beats expectations depends on validation of Q3 coal-price pass-through; we do not draw conclusions on behalf of the market, but simply offer our own range of RMB 300–450 mn.
Business model: Asset-heavy, resource-based — 11 producing mines in the Qinshui coalfield (approved capacity 15 mn tonnes/year, recoverable reserves of 643 mn tonnes, mine life of approx. 51 years) + pit-mouth chemicals (approx. 1 mn tonnes of urea, 1.2 mn tonnes after technical upgrade). Revenue has no subscription attributes and fluctuates entirely with coal and urea prices (weak pricing power: price -21.8% in 2025 → +16.3% in 2026H1, fully market-following); the value of the coal chemical business lies not in profitability (loss-making year after year) but in internal consumption of lump coal and policy-driven survival. The coal segment contributed approx. 84.5% of revenue and nearly all gross profit in 2026H1.
Cash content of earnings: OCF/net profit for 2023–2026H1 was 1.27 / 2.65 / 0.63 / 3.38 — the negative OCF in 2025 due to price declines and shrinking sales is "cyclical" rather than "receivables buildup" (top-five customer concentration of 21.3%, concentration does not constitute a red flag); H1 recovered to 3.38×. FCF/net profit: 1.98 in 2024, 1.88 in 2025 on the standard basis (-8.51 bn including the Sitou exploration right), negative in 2026H1 — currently in a "capex devouring cash" phase: H1 operating cash flow of RMB 281 mn vs. RMB 614 mn paid for purchases and construction. Recurring earnings test: 2025 net profit attributable to parent of -RMB 540 mn vs. recurring -RMB 852 mn, a gap of RMB 312 mn mainly from one-time non-operating gains of RMB 403 mn (refund of investment in an acquired wholly-owned subsidiary) — after stripping out non-recurring items, core losses were deeper; H1 attributable profit of RMB 83 mn and recurring profit of RMB 95 mn are directionally consistent, with acceptable quality.
Return on capital: ROIC approx. 3.6% in 2024 → approx. -1.1% in 2025 → annualized approx. 1.2% in 2026H1, far below the 8% warning line and WACC — substantial capital is tied up in exploration rights (RMB 7.31 bn) and construction in progress; returns will only materialize after the Luhe/upgrade/Sitou capacity cycle post-2027. Mid-cycle normalized ROE of approx. 6%, still below Lu'an/Hongyang's 7.6–7.7%.
Maintenance CapEx test: CapEx/depreciation: 0.25 in 2024, 0.72 in 2025 on the standard basis, annualized approx. 0.81 in 2026H1 — regular maintenance spending is below depreciation (cash-cow characteristics hold in normal coal-price years), but expansionary spending (exploration rights + technical upgrade + Luhe) is another ledger: 2025 CapEx including exploration rights reached 4.8× depreciation, all debt-financed.
Red flags: ① Minority shareholders systematically absorbing losses (see the section "Financial Engineering and Cross-Period Consistency"); ② the chemical segment, loss-making year after year, still receiving an additional RMB 3.962 bn of investment — investors publicly asked "why keep investing RMB 3.9 bn in coal chemicals that keep losing money," and the company offered no quantitative return analysis in response; ③ dividends suspended from 2025, with shareholder returns giving way to capital expenditure.
Consistency between words and deeds — "partially delivered": ① 2026 operating plan (revenue RMB 9.2 bn, profit RMB 200 mn, coal 14.5 mn tonnes): H1 revenue of RMB 4.792 bn (52% of schedule) and pre-tax profit of RMB 111 mn (55.5%) are basically on track, but the August chemical shutdown has distorted the H2 path, and the 14.5 mn tonne production target requires 7.57 mn tonnes in H2 (approx. 9% above H1), with downside revision risk; ② the 2024 buyback commitment of RMB 100–200 mn: actual execution of RMB 100.02 mn, completed at the lower bound; ③ charter dividend commitment (≥30% in profitable years): 53.1% for 2023 and 30.8% for 2024, both honored; no dividend for the loss-making 2025 — the commitment itself has been kept, but whether dividends resume after turning profitable in 2026 (consolidated undistributed profit of RMB 10.31 bn; note that A-share dividends are based on the parent company's distributable profits, which has not been verified on the parent-company basis) is the next test point.
Shareholder friendliness — "neutral to weak": Over the past three years, dividends + buybacks totaled RMB 1.435 bn, 189% of the three-year average net profit, but the cadence is entirely pro-cyclical: generous when coal prices are good (RMB 1.114 bn in 2023), halted when losses occur (zero dividends and buybacks in 2025–2026); meanwhile interest-bearing debt increased by approx. RMB 8.1 bn over two years — capital allocation clearly favors "buying resources" over "returning to shareholders."
Risk signals: Since August 2025, the Chairman (Liu Haishan → Zhao Chenguang), General Manager (change in October 2025), and Chief Accountant (dismissed upon reaching retirement age in September 2026; original term through June 2027; independent directors issued concurring opinions) have all changed within one year — the leadership transition overlaps in timing with the concentrated impairments in 2025Q4 (see E4); the related-party competition issue involving Dongfeng/Jushan coal mines under controlling shareholder Lanhua Group remains unresolved ("Dongfeng Coal Mine does not yet meet injection conditions"); in response to investors' public inquiries about "big bath accounting," the company only replied "thank you for your attention," lacking a positive, quantitative explanation. The company states that the Chief Accountant's dismissal was a normal transition upon reaching retirement age and that he still attended the mid-September earnings briefing — no evidence yet of disagreement over financial statements, but the change in the finance line, combined with the impairment pattern, warrants vigilance regarding the annual report's audit opinion and impairment items.
| Segment | 2026H1 revenue share | Gross margin | YoY | Business logic in one sentence |
|---|---|---|---|---|
| Coal (mainly anthracite) | 84.5% | approx. 32.3% (estimated) | Revenue +29.3% (product basis) | Absolute profit engine: H1 gross profit of RMB 1.304 bn, per-tonne coal gross profit approx. RMB 282 |
| Coal chemicals (fertilizer + chemicals) | 13.7% | -0.5% (fertilizer +15.1%; chemicals near-zero revenue yet loss-making) | 2025FY revenue -51.4% | Pit-mouth consumption of lump coal, locking in the coal–urea price spread; full shutdown from mid-August for technical upgrade |
| Others (trading/port/machinery) | 1.8% | approx. 42.4% (estimated) | — | Jiaxiang Port's H1 net profit of RMB 22.59 mn is a non-coal bright spot (62% acquired in 2025 for RMB 149 mn) |
Profit-driven segment: Coal — 84.5% revenue share × 32.3% gross margin contributes approx. RMB 1.304 bn of gross profit, while the coal chemical segment's gross profit is approx. -RMB 3 mn; coal, with about six times the chemicals segment's revenue share, contributed over 100% of segment gross profit. A 32.8-percentage-point gross margin gap: coal is a resource-endowment business (premium Qinshui coalfield chemical coal, scarce lump-coal premium), while chemicals is an overcapacity processing business (national urea surplus + export quota controls + internal transfer pricing for feedstock coal) — vastly different bargaining power; this is precisely the industry's profit-allocation pattern of "resource end keeps profits, processing end keeps revenue" as reflected in the company's statements. Yongsheng (thermal coal, 2025 price of RMB 263/tonne) and other small-to-mid integrated mines sit on the right tail of the cost curve — a structural drag within the coal segment.
Accounting red flags (pattern / severity / original-text evidence):
Cross-period consistency:
Overall judgment: red flags are concentrated in "cross-year profit placement" and "loss-sharing structure," directionally identifiable and trackable tendencies in financial engineering rather than pernicious revenue-fabrication issues; what they depress is the credibility of earnings and the valuation ceiling (part of the reason the market assigns 0.67× P/B lies here).
Reserves and production (2025 reserves report basis; resources/recoverable reserves/proved reserves, 100 mn tonnes): total 15.09 / 6.43 / 3.19; key mines: Tang'an 2.39/0.83/0.47, Bofang 2.53/1.42/0.19, Yuxi 2.06/1.25/0.61, Dayang 1.38/0.60/0.19, Yongsheng (thermal coal) 1.99/0.53/0.57; plus the Sitou exploration right adding 200+ mn tonnes of anthracite reserves (pending detailed exploration). Overall mine life of approx. 51 years (recoverable reserves / annual sales). 2025 production of 14.4416 mn tonnes (+4.2%); 2026H1 production of 6.9271 mn tonnes (-8.6%, safety-supervision-driven cuts), sales of 6.7218 mn tonnes (+11.2%). Reserve replacement ratio: the 2025 acquisition of Sitou (+200 mn tonnes) represents a static replacement ratio of approx. 13.8× that year's production — resource continuity is ample, but the monetization cycle lies beyond 2028. Mine-level P&L distribution (2025FY): profit-making mines Tang'an +201 mn / Dayang +86 mn / Yuxi +63 mn; loss-making mines Baisheng -225 mn / Qinyu -192 mn / Tongbao -134 mn / Yongsheng -126 mn — the profit divide between premium mines and small integrated mines is clear.
Unit economics: unit production cost of RMB 325.98 in 2024 → 306.11 in 2025 → 282.81 in 2026H1 per tonne; full cost including surcharges and management allocations of approx. RMB 395/tonne in 2026H1 (approx. RMB 430–440 on an all-in basis), yielding per-tonne gross profit of approx. RMB 170–230 against a price of RMB 565. AISC not disclosed; cost position is mid-tier to favorable among listed anthracite producers (Qinshui coalfield chemical coal endowment), but small-to-mid integrated mines sit on the right tail. Sensitivity: coal price ±10% (±RMB 56/tonne) → EBITDA ±28%, attributable profit ±61% (±RMB 560 mn) — leverage amplifies coal-price volatility into valuation volatility; net interest-bearing debt / mid-cycle EBITDA of approx. 4.4×, with free cash flow turning negative at -10% coal prices. Hedging: no hedging positions disclosed; prices fully exposed to spot.
Geopolitical and mining rights risks: all assets are in Jincheng, Shanxi (stable political and policy environment; main risks are safety and environmental supervision rather than geopolitics); the Jiazhai exploration right was placed on a proposed self-revocation list (renewal procedures incomplete) — a real precedent in the exploration-to-mining chain; Sitou is in exploration-to-mining verification and reserve filing stages. Environmental precedent: the Chemical Branch was ordered to halt production for 90 days in October 2024.
NAV perspective (three approaches presented side by side): reserves-based RMB 2.2–5.2/share (643 mn tonnes recoverable × RMB 8–15/tonne + Sitou at cost + chemical replacement of approx. RMB 2.5 bn − net debt of RMB 11.37 bn); replacement cost RMB 8.5–13.5/share (14.5 mn tonnes × RMB 1,000–1,500/tonne); book value RMB 10.36/share. The core dispute centers on Sitou: the company's actual transaction price of RMB 34.7/tonne of resources (approx. RMB 70–85/tonne recoverable) is 5–9× the coking coal comparable of RMB 8.64/tonne recoverable — if Sitou is revalued at the coking coal comparable unit price, NAV would fall below approx. RMB 1/share. The RMB 4–8/share gap between the reserves-based and replacement-cost approaches shows that "at what price resources are carried on the books" is itself the biggest valuation disagreement for this stock; the current price of RMB 6.99 is above the reserves-based midpoint but below the replacement cost and book value.
Current market data (close of 2026-10-08): share price RMB 6.99, market cap RMB 10.298 billion, PB 0.67 (77th percentile over the past 1 year / 43rd over 3 years / 26th over 5 years / 27th over 10 years; historical range 0.50–1.53, median 0.80–0.83); PE (TTM) negative (2025 loss), percentiles are for reference only, not a cheap/expensive signal—at a cyclical trough plus the first year of a turnaround, PE is mechanically distorted. Forward measures: current price / consensus FY2026 EPS of RMB 0.21 = 33.3x; current price / our FY2026 central EPS of RMB 0.25 = 27.5x; current price / mid-cycle normalized EPS of RMB 0.63 = 11.1x—the 11x mid-cycle multiple is the more informative measure.
Peer benchmarking (same day, same source, 2026-10-08):
| Company | PB | 2026H1 revenue growth | 2026H1 ROE (annualized) | PB / mid-cycle ROE | Notes |
|---|---|---|---|---|---|
| Lanhua Sci-Tech | 0.67 | +18.3% | ~1.1% | 0.110 | Zero dividends, net debt/EBITDA 4.4x, dual overhangs from chemicals + arbitration |
| Lu'an Environmental Energy | 0.98 | +6.7% | 7.7% | 0.127 | PCI coal leader, historically net cash + high dividends |
| Huayang Co. | 1.19 | -11.7% | 7.6% | 0.157 | Pure coal + sodium-ion battery transformation premium |
| Haohua Energy | 1.52 | +9.5% | N/A | — | Strongest this round (YTD +82%), PB at the 94th percentile of 10 years |
On current ROE, Lanhua's discount is entirely justified (ROE 1.1% vs. peers' 7.6–7.7%; PB paid per unit of ROE is actually higher); on mid-cycle ROE of 6.1%, PB per unit of ROE is 0.110 vs. peers' 0.127–0.157—a 13–30% discount, which is relatively deep, with a substantial portion explained by leverage and governance.
Market-implied expectations: reverse valuation shows the current price implies mid-cycle recurring net profit attributable of ~RMB 980 million (implied own-mined coal price ~RMB 567/ton)—"the current price requires the company to sustainably achieve RMB 567/ton and ~RMB 1 billion net profit, whereas reality: H1 already realized RMB 565/ton, full-year central estimate RMB 375 million, and 2023 achieved RMB 2.1 billion." The market is pricing at "current price sustainably": paying nothing for further coal price upside and not deeply pricing downside; the three options—Yamei resumption, technical upgrades coming online, and the Sitou revaluation—are being paid a combined ~RMB 1.87/share (27% of the current price).
Three-layer value (EPV): asset value (liquidation floor) ~RMB 2.2–5.2/share (reserve method, see the "Resource Stock Special" section); zero-growth EPV RMB 5.12/share (unlevered normalized EPS 0.86 ÷ WACC 6.7% − net debt per share RMB 7.72; cost of equity ~10.5%×47.5% + after-tax debt 3%×52.5%); growth/recovery option RMB 1.87/share (26.8% of current price, computed by the system from actual EPV inputs)—the current price is mainly supported by the "profitability layer," with the asset layer as a floor reference. To be honest: this framework is sensitive to the discount rate; raising COE to 10% lowers fair value to ~RMB 6.65 (below the current price)—the quality of the margin of safety depends on sustained coal price strength and deleveraging, not merely static discounting.
Three scenarios and odds (12-month horizon):
| Scenario | Probability | Fair range | vs. current price | Key drivers |
|---|---|---|---|---|
| Bear | 28% | RMB 4.8–5.5 | -21% to -31% | Coal price falls back to RMB 450–480/ton (supply-resumption quota of 31 million tons materializes + weaker winter stocking), net profit ≈0 to -RMB 200 million; plus Daning impairment of RMB 340 million and year-end impairment inertia; PB 0.48–0.54×BPS≈10.1 (52-week low RMB 5.58 = 0.54× as a validated market bottom) |
| Base | 52% | RMB 7.8–8.3 | +11.6% to +18.7% | 2026 net profit RMB 300–450 million + 2027 recovery toward mid-cycle RMB 700–1,100 million (Luhe startup + technical upgrade ramp + neutral Daning case); exit PB 0.75×2027E BPS 10.7—anchored to Lu'an 0.98× ROE-ratio-implied 0.78 and the company's 5-year PB median 0.83, independent of the current price |
| Bull | 20% | RMB 11.8–12.8 | +69% to +83% | Coal price surges to RMB 600–650/ton + Daning extension approved and resumption (+RMB 200–250 million/year) + chemical upgrades at full capacity and efficiency, net profit RMB 1.6–1.9 billion, ROE ~11%; exit PB 1.0–1.05 anchored to the lower-middle range of Haohua 1.52 / Huayang 1.19 (current multiples of "inflection-point realized" companies)—requires all three conditions; exceeds all currently published target prices (highest RMB 8.55) |
Probability-weighted fair value ~RMB 8.09 (expected return +15.7%). Our own earnings forecast (the anchor for next earnings reconciliation): FY2026 revenue RMB 8.6–9.2 billion, net profit RMB 300–450 million (EPS 0.20–0.31); FY2027 revenue RMB 9.2–10.2 billion, net profit RMB 700–1,100 million—placed alongside management (9.2bn / 200 million) and sell-side consensus (309 million / 430 million); our point of divergence is believing consensus has not yet reflected the Q3 spot price surge, but has already deducted the chemicals shutdown and impairment inertia.
Conclusion: Reasonably low, target price RMB 7.8–8.3 (= base-case fair value), margin of safety +12% (vs. base-case floor). Separate quality from price: the resources are real (51-year mine life, ~3.6% anthracite share, lowest PB among all peers); the weaknesses are real (net debt RMB 11.37 billion, zero dividends, dual overhangs of chemicals and arbitration, integrated-mine losses); the price already embeds most weaknesses, and the remaining dispute is "whether mid-cycle ROE of ~6% can be realized."
1. Industry size. The company's true niche is Chinese anthracite (the Jincheng production area is the nation's largest base) and the synthetic ammonia–urea chain using anthracite lump coal as feedstock. National anthracite output is approaching 400 million tons/year (CCTD "2025 China Anthracite Market White Paper"), of which Shanxi accounts for ~63% (~250 million tons); Jincheng is the nation's largest anthracite production base, with proven coal reserves of 27.33 billion tons at the reserves scope, of which anthracite accounts for over half of Shanxi and over a quarter of the nation; the "15th Five-Year Plan" keeps Jincheng raw coal output at 1.4 billion tons or above. For context: 2025 national raw coal output of large enterprises was 4.83 billion tons (NBS, +1.2%; full-scope statistical communiqué 4.85 billion tons / +1.4%), with anthracite ~8% of national coal output. On growth: anthracite consumption growth ~0.9% in both 2025 and 2026 (CCTD White Paper forecast)—a mature plateau industry; the total-volume story is over; 2025 national thermal power generation -1.0% (first negative growth since 2016), thermal coal demand has peaked, and differentiation among coal types is intensifying: scarce lump coal relatively benefits while fines coal stays under long-term pressure. Lanhua's 14.5 million tons/year output corresponds to ~3.6% of national anthracite.
2. Value chain and value distribution. The chain is "mines → washing and sizing → lump coal (fixed-bed gasification / PCI) + fines coal (thermal coal) → fertilizer / steel / power." The key to value distribution is the spread between coal types: on 2026-09-30, Jincheng washed anthracite mid-lump ex-works price RMB 1,560/ton vs. Qinhuangdao 5,500 kcal spot ~RMB 990/ton—lump coal premium ~58% (including calorific differential and scarcity premium). The correlation between anthracite and urea prices is ~0.90, and Jincheng is also the national urea capacity hub, forming a regional "lump coal–urea" symbiosis. Lanhua sits in the "resources + mine-mouth chemical integration" segment: coal segment H1 gross margin ~32–34%, urea segment ~15–18%—profit stays at the resource end; the processing end is thin in value but provides internal absorption of lump coal; strong bargaining power over downstream fertilizer plants (scarce coal type + regionally concentrated supply), weak bargaining power over urea buyers (national overcapacity + export quota controls + supply-security price caps).
3. Supply-demand and competitive landscape. Demand side: chemical-use lump coal is ~45% of anthracite consumption, steel PCI ~21%, fines coal tracks thermal coal; the 2026 price rise is driven by supply contraction, not demand expansion—after the May "5·22" mine accident in Qinyuan, safety supervision became normalized; on August 27, the National Mine Safety Administration extended oversight from private mines to state-owned mines; Shanxi raw coal output fell -31.5%/-35.8% YoY in June/July; the supply cliff drove Qinhuangdao spot from RMB 689 at the start of the year to ~RMB 990 in September (+43.7%, ~61st percentile of the range since 2023), and Bohai Rim market coal topped RMB 1,000 for the first time in three years. Offset on supply: on September 26 the Shanxi governor chaired a stable-production and stable-supply meeting, with the market estimating ~31 million tons of resumption increments—this is the biggest bearish force for Q4 coal prices, tussling with peak-winter demand. Concentration: anthracite concentration is moderately low; Jinneng Equipment Group (formerly Jinneng Coal) accounts for ~20% nationally, followed by Huayang (Yangquan mining area) and Lanhua (the second-largest listed platform in the Jincheng area); the top three groups are roughly ~30% combined (group-scope rough estimate; no authoritative CR3 disclosure). Entry barriers are extremely high: resources exist only in a few mining areas such as Jincheng/Yangquan/Jiaozuo with new mining rights essentially frozen, safety compliance costs keep rising, and mine-mouth integration is hard to replicate. Competitive threats lie not at the mine end (regional oligopoly, price taker) but in two places: on urea, national overcapacity (Jan–Aug 2026 output +7%, operating rates 85–90% at historical highs, export quotas only 3.3 million tons with strict inspection) intensifying involution; and on coal types, medium-term substitution is real—semi-coke/cheap bituminous cost-performance substitution in PCI, and after fixed-bed UGI retires in favor of entrained-flow gasifiers, bituminous coal becomes usable—both eroding long-term lump coal demand (no authoritative retirement timetable; a slow variable).
4. Cycles and regulation. Historical cycle template (Qinhuangdao 5,500 kcal basis): 2015 trough RMB 409 (overcapacity + property downturn, trough period ~4 years) → 2016–17 policy reversal (276 working days + capacity cuts) → 2021–22 peak RMB 1,202 (industrial power surge + energy crisis, peak zone 4–5 quarters) → 2023–25 three-year grind lower (1,185→927→769→689 RMB, supply-security quota increases + high imports + renewables substitution) → 2026's supervision-driven "passive rally": unlike 2021's demand-driven move, this round's upside is constrained by demand. Current positioning: Qinhuangdao spot ~RMB 990 at ~61st percentile since 2023, equivalent to 82% of the 2021 peak composite price; Jincheng anthracite mid-lump at RMB 1,560 is ~10% below the 2022-04 mine-mouth high of RMB 1,740—anthracite lump is at a three-year high but not at 2021–22 extremes. Leading indicators: Shanxi/national daily output and safety-supervision resumption progress (primary variable), Qinhuangdao inventories (~11.49 million tons in September, 2.42 million tons higher YoY), power plant daily consumption and days of cover (20.5 days), Indonesian exports to China (August -30.8%, import replenishment weakening). Regulatory direction: normalized safety supervision (bearish for output, bullish for the price center, squeezing out small scattered capacity to the benefit of compliant large mines), urea export quota system (suppressing chemicals elasticity but flooring domestic prices), thermal coal long-term contracts and price band controls (the company's 2026 supply-security thermal coal of 7.1349 million tons locks in low prices with long goods-first payment terms, dampening average price elasticity)—on balance this combination favors Lanhua, which "has mines, is compliant, and is integrated," and hurts chemical players without resources.
5. Peer benchmarking (operating scope; valuation multiples in the "Valuation and Odds" section):
| Company | 2026H1 revenue | Revenue growth | Gross margin | ROE (H1 annualized) | Scale ranking / differences |
|---|---|---|---|---|---|
| Lanhua Sci-Tech | RMB 4.792 billion | +18.3% | 28.0% (coal segment 32–34%) | ~1.1% | ~3.6% anthracite share, second-largest listed platform in Jincheng; mine-mouth chemical integration, lowest PB among all peers |
| Huayang Co. | RMB 9.921 billion | -11.7% | ~43% (TTM) | 7.6% | Yangquan mining area leader, ~2x Lanhua's size, pure coal without urea burden + sodium-ion new materials |
| Lu'an Environmental Energy | RMB 15.010 billion | +6.7% | 40.1% | 7.7% | PCI coal leader; H1 net profit RMB 1.778 billion is 21x Lanhua's; high dividends |
| Haohua Energy | RMB 4.811 billion | +9.5% | N/A (H1 net profit +66%) | N/A | Anthracite + Mongolian coal dual structure; strongest this round (YTD +82%) |
Lanhua's relative profile is clear: smallest in scale, lowest ROE (first year of loss recovery + chemicals drag + integrated-mine losses), lowest PB (0.67)—the market prices it as a "low valuation, high safety-supervision price elasticity" small-cap anthracite play, not a profit-quality leader. H1 revenue growth (+18.3%) is actually the highest of the four; the elasticity direction is beginning to materialize.
6. Company industry positioning: a niche incumbent among the chasers—~3.6% share with a stable trend (new mines like Yuxi offsetting declines at older mines); the moat comes from resource endowment (high-quality chemical coal in the Qinshui coalfield, new mining rights nearly frozen) and mine-mouth integration (internal conversion of lump coal locks in the coal–urea spread), not cost or scale. A scope difference to note side by side: the company's annual report, citing industry scope, says Jincheng's anthracite reserves are "over a quarter of the nation," which is the Jincheng municipal government / industry association scope; the CCTD White Paper scope is "Shanxi holds 63% of national anthracite, with Jincheng the largest base"—the two scopes point in the same direction but use different numerical systems; when citing, official upstream statistics should prevail.
Overall judgment: cautiously bullish (confidence 0.55, 12 months). The earnings inflection has been doubly validated by H1 results and Q3 coal prices, but valuation repair is also more than half done—the current price of RMB 6.99 sits ~12–19% below base-case fair value of RMB 7.8–8.3, with a margin of safety +12% (vs. base-case floor) and probability-weighted expected return +15.7%; symmetrically, the bear case implies -21% to -31% downside. This odds structure supports staged participation at milestones: Q3 results (coal price pass-through), arbitration ruling (directional event), and mid-handover/trial production of technical upgrades (execution validation)—each of these three checkpoints provides information for adding or exiting, rather than building the position all at once. If 2027 mid-cycle earnings (net profit RMB 700–1,100 million) and the deleveraging path materialize, the valuation anchor will switch from "distressed-discount PB" back to "dividend-asset PB," at which point the return driver will be earnings and dividend recovery rather than multiple expansion.
Key risks (written notice): a coal price pullback (spot falling below RMB 800/ton) would reverse the full-year turnaround logic; Yamei Daning arbitration ruling against extension brings one-off impairments and a permanent loss of profit stream; technical upgrade delays or weak urea prices after startup creating a second bleeding point; the reporting惯性 of concentrated year-end impairments; credit channel narrowing under high leverage. Monitoring points: Q3 per-ton coal price and net profit, weekly Jincheng lump coal mine-mouth price index and Qinhuangdao inventories, materialization of Shanxi resumption increments, 10-31 mid-handover and 12-31 trial production announcements, arbitration ruling announcement, terms of the RMB 3 billion corporate bond issuance, 2026 annual report dividend proposal. Even in the upside scenario, disciplined exits are required: once the share price enters the upper edge of the RMB 8.3 target range, the margin of safety is exhausted and re-evaluation is needed rather than habitual holding.
This report uses the 2026-10-08 closing price of RMB 6.99 as the price benchmark (completed-trading-day close basis). All multiple percentiles are quoted from same-day, same-source valuation data of 2026-10-08. This report is an update; for changes in conclusions versus the previous report of 2026-07-03, see Section I.